Search research articles
Contact Us
Filters
Showing results (141-150 of 183) with videos related to
Page
of 19
Sort By:
Leukemia & Lymphoma
|
July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission
Kevin W Song, Peter N Mollee, Donna E Hogge, et al.
Plos One
|
November 19, 2010
Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)
Linh T Nguyen, Pei Hua Yen, Jessica Nie, et al.
NPJ Precision Oncology
|
June 3, 2026
Detection and classification of lymphoma from cell-free methylome data
Victoria B Shelton, Mohamed Alias, Ting Liu, et al.
British Journal of Haematology
|
May 27, 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP
Douglas A Stewart, John Kuruvilla, David Lee, et al.
Leukemia & Lymphoma
|
June 15, 2026
Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma
Inna Y Gong, Naomi M Xiao, Christine Chen, et al.
JCO Precision Oncology
|
July 9, 2025
Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma
Davidson Zhao, Noémie Lang, Ting Liu, et al.
British Journal of Haematology
|
October 11, 2014
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis
Kevin H M Kuo, Jeannie L Callum, Tony Panzarella, et al.
Leukemia & Lymphoma
|
October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group
Matthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
The Lancet. Oncology
|
July 5, 2011
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
Bertrand Coiffier, Evgenii A Osmanov, Xiaonan Hong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2009
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082
Lawrence B Marks, Constance Cirrincione, Thomas J Fitzgerald, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 183) with videos related to
Sort By:
Page
of 19
Leukemia & Lymphoma
|
July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission
Kevin W Song, Peter N Mollee, Donna E Hogge, et al.
Plos One
|
November 19, 2010
Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)
Linh T Nguyen, Pei Hua Yen, Jessica Nie, et al.
NPJ Precision Oncology
|
June 3, 2026
Detection and classification of lymphoma from cell-free methylome data
Victoria B Shelton, Mohamed Alias, Ting Liu, et al.
British Journal of Haematology
|
May 27, 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP
Douglas A Stewart, John Kuruvilla, David Lee, et al.
Leukemia & Lymphoma
|
June 15, 2026
Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma
Inna Y Gong, Naomi M Xiao, Christine Chen, et al.
JCO Precision Oncology
|
July 9, 2025
Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma
Davidson Zhao, Noémie Lang, Ting Liu, et al.
British Journal of Haematology
|
October 11, 2014
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis
Kevin H M Kuo, Jeannie L Callum, Tony Panzarella, et al.
Leukemia & Lymphoma
|
October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group
Matthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
The Lancet. Oncology
|
July 5, 2011
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial
Bertrand Coiffier, Evgenii A Osmanov, Xiaonan Hong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2009
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082
Lawrence B Marks, Constance Cirrincione, Thomas J Fitzgerald, et al.
Page
of 19